ISPC

iSpecimen Inc.

NasdaqAdd to watchlist

Healthcare · Diagnostics & Research

$1.35

−$0.02−1.46%

Delayed · 2026-09-17T20:00:00.000Z · marketstack

Aug 24, 2026$1.35

−$0.22−14.01%over 1M

Session

Day range45% of range

$1.30$1.41

Fundamentals

Visualize fundamentals and more

Market cap: 1.88M
P/E ratio: -

Revenue grew −79.24% in FY2025, +88.10% slower than its sector. The median across Healthcare companies this platform tracks is +8.87%.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed April 2025.

Litigation
Data privacy
Going concern
Russia and Ukraine
Cybersecurity
Export controls
Debt covenants
Inflation

And 9 more.

Litigation
Any such claims, with or without merit, could cause costly litigation that could consume significant management time. As the number of product and services offerings in our market increases and functionalities increasingly overlap, companies such as ours may …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

40 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 17, 2026 · the last close

iSpecimen Inc. investor relations

What ISPC has filed with the SEC. This is not iSpecimen Inc.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like iSpecimen Inc.

Also filed under Diagnostics & Research, ranked by how closely they sit beside ISPC.

TMOThermo Fisher Scientific Inc.compare with ISPC
ILMNILLUMINA, Inc.compare with ISPC
DHRDanaher Corp.compare with ISPC
TWSTTwist Bioscience Corp

What an account lets you do with iSpecimen Inc.

Be told the moment a ISPC insider trades
Put iSpecimen Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
iSpecimen Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about iSpecimen Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed April 2025.

Litigation
Data privacy
Going concern
Russia and Ukraine
Cybersecurity
Export controls
Debt covenants
Inflation

And 9 more.

Litigation
Any such claims, with or without merit, could cause costly litigation that could consume significant management time. As the number of product and services offerings in our market increases and functionalities increasingly overlap, companies such as ours may …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Session

Fundamentals

What it says it is exposed to

Recent activity

Discussion

iSpecimen Inc. investor relations

Companies like iSpecimen Inc.

Ask about iSpecimen Inc.

What an account lets you do with iSpecimen Inc.

Recent activity

What it says it is exposed to